John Kenneth Hall - Publications

Affiliations: 
2010 Molecular, Cellular and Developmental Biology University of Colorado, Boulder, Boulder, CO, United States 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Benasutti H, Maricelli JW, Seto J, Hall J, Halbert C, Wicki J, Heusgen L, Purvis N, Regnier M, Lin DC, Rodgers BD, Chamberlain JS. Efficacy and muscle safety assessment of fukutin-related protein gene therapy. Molecular Therapy. Methods & Clinical Development. 30: 65-80. PMID 37361354 DOI: 10.1016/j.omtm.2023.05.022  0.468
2022 Desjardins CA, Yao M, Hall J, O'Donnell E, Venkatesan R, Spring S, Wen A, Hsia N, Shen P, Russo R, Lan B, Picariello T, Tang K, Weeden T, Zanotti S, et al. Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice. Nucleic Acids Research. PMID 35944903 DOI: 10.1093/nar/gkac641  0.345
2019 Kolwicz SC, Hall JK, Moussavi-Harami F, Chen X, Hauschka SD, Chamberlain JS, Regnier M, Odom GL. Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate. Jacc. Basic to Translational Science. 4: 778-791. PMID 31998848 DOI: 10.1016/J.Jacbts.2019.06.006  0.624
2017 Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS. Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 16007. PMID 28643790 DOI: 10.1038/Ncomms16007  0.69
2017 Hall MN, Hall JK, Cadwallader AB, Pawlikowski BT, Doles JD, Elston TL, Olwin BB. Transplantation of Skeletal Muscle Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1556: 237-244. PMID 28247353 DOI: 10.1007/978-1-4939-6771-1_12  0.746
2017 Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 14454. PMID 28195574 DOI: 10.1038/Ncomms14454  0.709
2016 Bengtsson NE, Hall JK, Odom GL, Allen J, Chamberlain JR, Chamberlain JS. 501. In Vivo Gene Editing for Duchenne Muscular Dystrophy Molecular Therapy. 24: S199. DOI: 10.1016/S1525-0016(16)33310-X  0.477
2015 Bengtsson NE, Seto JT, Hall JK, Chamberlain JS, Odom GL. Progress and prospects of gene therapy clinical trials for the muscular dystrophies. Human Molecular Genetics. PMID 26450518 DOI: 10.1093/Hmg/Ddv420  0.33
2015 Hall JK, Mozaffarian LL, Chamberlain JS. 617. Histologic Assessment of Geriatric Esophagus Revels Therapeutic Targets in Wild-Type and Dystrophic Mouse Models Molecular Therapy. 23: S245. DOI: 10.1016/S1525-0016(16)34226-5  0.5
2015 Bengtsson NE, Hall JK, Lieber AM, Chamberlain JS. 613. Characterization of IPSC-Derived Myogenic Progenitors Isolated from Mouse Models of Duchenne Muscular Dystrophy Molecular Therapy. 23: S243-S244. DOI: 10.1016/S1525-0016(16)34222-8  0.656
2014 Arnett AL, Konieczny P, Ramos JN, Hall J, Odom G, Yablonka-Reuveni Z, Chamberlain JR, Chamberlain JS. Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Molecular Therapy. Methods & Clinical Development. 1. PMID 25580445 DOI: 10.1038/Mtm.2014.38  0.614
2014 Faber RM, Hall JK, Chamberlain JS, Banks GB. Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice. Skeletal Muscle. 4: 10. PMID 24910770 DOI: 10.1186/2044-5040-4-10  0.585
2014 Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, Olwin BB. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nature Medicine. 20: 265-71. PMID 24531379 DOI: 10.1038/Nm.3465  0.597
2012 Parker MH, Loretz C, Tyler AE, Duddy WJ, Hall JK, Olwin BB, Bernstein ID, Storb R, Tapscott SJ. Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells (Dayton, Ohio). 30: 2212-20. PMID 22865615 DOI: 10.1002/Stem.1181  0.773
2012 Ng R, Banks GB, Hall JK, Muir LA, Ramos JN, Wicki J, Odom GL, Konieczny P, Seto J, Chamberlain JR, Chamberlain JS. Animal models of muscular dystrophy. Progress in Molecular Biology and Translational Science. 105: 83-111. PMID 22137430 DOI: 10.1016/B978-0-12-394596-9.00004-4  0.357
2010 Hall JK, Banks GB, Chamberlain JS, Olwin BB. Prevention of muscle aging by myofiber-associated satellite cell transplantation. Science Translational Medicine. 2: 57ra83. PMID 21068442 DOI: 10.1126/Scitranslmed.3001081  0.792
2009 Tanaka KK, Hall JK, Troy AA, Cornelison DD, Majka SM, Olwin BB. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell. 4: 217-25. PMID 19265661 DOI: 10.1016/J.Stem.2009.01.016  0.722
Show low-probability matches.